BIO-PATH Holdings 8-K: Shareholder Vote Matters Filed Jan 22

TL;DR

**BPTH filed an 8-K about shareholder votes, signaling upcoming corporate decisions.**

AI Summary

BIO-PATH HOLDINGS, INC. (BPTH) filed an 8-K on January 23, 2024, reporting an event that occurred on January 22, 2024, related to the submission of matters to a vote of security holders. This filing indicates that the company's common stock, with a par value of $0.001 per share, is registered on The Nasdaq Capital Market under the trading symbol BPTH. For investors, this matters because it signals that significant corporate actions requiring shareholder approval are underway, which could impact the company's future direction and stock value.

Why It Matters

This filing indicates that BIO-PATH HOLDINGS, INC. is engaging its shareholders on important corporate decisions, which could lead to changes in company strategy or structure. Such votes often precede or follow significant business developments that can influence the stock's performance.

Risk Assessment

Risk Level: medium — The risk is medium because while the filing itself is administrative, the underlying shareholder vote could involve significant, potentially risky, corporate actions.

Analyst Insight

A smart investor would monitor BIO-PATH HOLDINGS, INC.'s subsequent filings (like proxy statements) to understand the specific matters being put to a shareholder vote, as these details will reveal the potential impact on the company's future and stock value.

Key Numbers

• $0.001 — par value per share (the stated par value of BIO-PATH HOLDINGS, INC.'s common stock)

Key Players & Entities

• BIO-PATH HOLDINGS, INC. (company) — the registrant filing the 8-K
• The Nasdaq Capital Market (company) — the exchange where BPTH common stock is registered
• $0.001 (dollar_amount) — par value per share of common stock
• January 22, 2024 (date) — date of the earliest event reported
• January 23, 2024 (date) — date the 8-K was filed

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M

Filing Documents

• bpth-20240122x8k.htm (8-K) — 38KB
• 0001558370-24-000438.txt ( ) — 156KB
• bpth-20240122.xsd (EX-101.SCH) — 3KB
• bpth-20240122_lab.xml (EX-101.LAB) — 16KB
• bpth-20240122_pre.xml (EX-101.PRE) — 10KB
• bpth-20240122x8k_htm.xml (XML) — 5KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On January 22, 2024, Bio-Path Holdings, Inc. (the "Company") convened a special meeting (the "Special Meeting") of stockholders of the Company at which a quorum was present. The Special Meeting was called for the following purposes: 1. To approve an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock, par value $0.001 per share, at a ratio of up to 1-for-50, to be determined by the Board ("Proposal One"); and 2. To approve an adjournment of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal One ("Proposal Two"). The sole item of business presented to stockholders for consideration at the Special Meeting was a vote on Proposal Two. The final voting results for Proposal Two are set forth below. Proposal Two : For the approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal One: Shares Voted "For" Shares Voted "Against" Shares Withheld Shares Abstained Broker Non-Votes 4,051,335 2,309,505 -- 70,837 289,343 In accordance with the authority granted pursuant to Proposal Two, the Special Meeting was adjourned with respect to Proposal One to solicit additional proxies in favor of Proposal One . As announced at the Special Meeting, the Special Meeting will reconvene on January 30, 2024 at 4:00 p.m. Central Standard Time at the offices of Winstead PC, 24 Waterway Avenue, Suite 500, The Woodlands, Texas 77380. The record date for the Special Meeting will remain December 28, 2023.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: January 23, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR